Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

20061,711 citationsJournal Article

Authors

Good health and well-being

Published in: Gastroenterology

Volume 130, Issue 2, pp. 323-333

Field-Weighted Citation Impact: 65.31